secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARS Pharmaceuticals, Inc. (SPRY)
CIK:        0001671858
Form:       8-K
Filed at:   2023-06-28T23:59:59+00:00
Accession:  0001193125-23-177543
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

ARS Pharmaceuticals stockholders elect three Class III directors at 2023 annual meeting
--------------------------------------------------------------------------------

- Elected Saqib Islam, Phillip Schneider, Laura Shawver as Class III directors to serve until 2026.
- Director vote results: Islam 70.4M for, 3.4M withheld; Schneider 68.7M for, 5.1M withheld; Shawver 69.7M for, 4.1M withheld.
- Ratified Ernst & Young as independent auditor for FY2023 with 79.1M votes for, 5,126 against, 4,843 abstentions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671858/000119312523177543/0001193125-23-177543-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671858/000119312523177543/d525934d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-177543

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer